SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-020855
Filing Date
2022-11-01
Accepted
2022-11-01 16:20:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_-_non_xbrl.htm DEFA14A 16799
2 GRAPHIC img193749221_0.jpg GRAPHIC 76719
3 GRAPHIC img193749221_1.jpg GRAPHIC 68431
  Complete submission text file 0000950170-22-020855.txt   207208
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36150 | Film No.: 221350514
SIC: 2836 Biological Products, (No Diagnostic Substances)